Search
for
Sort by
Research 61–90 of 1000+
- Impact of Treatment with Rosiglitazone or Metformin on Biomarkers for Insulin Resistance and Metabolic Syndrome in Patients with Polycystic Ovary Syndrome
- Insulin Resistance and Polycystic Ovary Syndrome
- Elevated fasting insulin is associated with cardiovascular and metabolic risk in women with polycystic ovary syndrome
- Insulin sensitiser agents alone and in co-treatment with r-FSH for ovulation induction in PCOS women
- When should an insulin sensitizing agent be used in the treatment of polycystic ovary syndrome?
- Afamin serum concentrations are associated with insulin resistance and metabolic syndrome in polycystic ovary syndrome
- A Review on Drug Induced Alopecia
- Insulin resistance and β-cell dysfunction and the relationship with cardio-metabolic disorders among women with polycystic ovary syndrome
- Repositioning Old Drugs for New Battles: The Expanding Role of Drug Repurposing in Cancer, Inflammation, and Metabolic Disease.
- Cutaneous Clues to Metabolic Dysfunction: Dermatological Manifestations of Diabetes and Insulin Resistance in Clinical Practice
- Differential plasma proteome analysis reveals key proteins associated with insulin resistance in acne vulgaris patients
- Association Between Insulin Resistance and Hyperandrogenism in Women with PCOS. A Cross-Sectional Clinical Study
- Unravelling the link between insulin resistance and androgen excess
- The investigation and management of severe hyperandrogenism pre- and postmenopause: Non-tumor disease is strongly associated with metabolic syndrome and typically responds to insulin-sensitization with metformin
- The modern scientific interpretation of ancient wisdom: a review of the phytochemistry and pharmacology of Erzhi Pill and its constituent botanical drugs
- Medication Repurposing: New Uses for Old Drugs
- Syndromes of Severe Insulin Resistance (SSIRs)
- Recent progress in PLGA-based microneedle-mediated transdermal drug and vaccine delivery
- Alternative treatment of polycystic ovary syndrome: pre-clinical and clinical basis for using plant-based drugs
- Natural products and their derivatives as candidate treatments for hair greying: from drug discovery to molecular mechanisms
- Hair Loss in a Hemodialysis Patient after Repetitive Use of the Antipruritic Drug Nalfurafine: Implications of Impaired Angiogenesis for Hair Loss
- Hair growth effects of Laminaria japonica extract and growth factor mixture on a C57BL/6 mouse model
- EFFICACY OF FLAXSEED CRACKERS IN AMELIORATING CLINICAL AND BIOCHEMICAL HYPERANDROGENISM IN YOUNG ADULT SOUTH INDIAN WOMEN DIAGNOSED WITH PCOS
- Cardiometabolic profile of young women with hypoprolactinemia
- Cross-sectional study of the association between skin tags and vascular risk factors in a bariatric clinic-based cohort of Irish adults with morbid obesity
- Compendium of polycystic ovarian syndrome and its relevance in glycation and diabetes
- Clinical aspects of the metabolic syndrome
- Potential role and therapeutic interests of myo-inositol in metabolic diseases
- Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome
- Polycystic Ovary Syndrome and Its Differential Diagnosis